Entera Bio Ltd. — Director's Dealing 2022

Jan 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-14

Reporting Person: Toledano Miranda Jayne (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-14	Ordinary Shares, par value NIS 0.0000769 per share	P	6800	$2.7899	Acquired	6800	Direct